Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

AZD 6482 Catalog No.:M10943-2 1alpha(OH)D3 and BCI-210 suppress PTH

SKU: 15887225211

4.8
USD90.00 USD128.00

Pay in 4 interest-free payments of $22.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Live Spec

AZD 6482 Catalog No.:M10943-2 1alpha(OH)D3 and BCI-210 suppress PTHAZD6482 is a potent, selective and ATP competitive PI3K inhibitor (IC(50) 0. 01 m). AZD6482 inhibited insulin induced human adipocyte glucose uptake in vitro (IC(50) of 4. 4 m). This is the first human target validation for PI3K inhibition as anti platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at

Store: vanlokventuinen.nl · Domain: vanlokventuinen.nl

Description

1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells

InChi: InChI=1S/C26H24F3N7O3S/c27-26(28

PubMed Central PMCID: PMC4036342

selective and cell-permeable p38 MAP kinase inhibitor with IC50 of 89 nM

InChi: InChI=1S/2C14H28O2

AZD 6482 Catalog No.:M10943-2 1alpha(OH)D3 and BCI-210 suppress PTHAZD6482 is a potent, selective and ATP competitive PI3K inhibitor (IC(50) 0. 01 m). AZD6482 inhibited insulin induced human adipocyte glucose uptake in vitro (IC(50) of 4. 4 m). This is the first human target validation for PI3K inhibition as anti platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products